Pyramidion Technology Group, Inc., today announced the execution of the closing of the acquisition of NxGen Brands, LLC of Denver, Colorado. PYTG officially owns NxGen operations, brands, marketplace and is currently now a subsidiary of Pyramidion Technology Group, Inc.
NxGen Brands, established CBD alternative medicine and natural nutraceutical products, owned, and is doing business as, LeafyWell. PYTG’s acquisition of NxGen Brands includes the acquisition of LeafyWell and there have been reports of significant additions to the company’s advisory board to now include experienced medical professionals to serve active roles in shaping the company’s direction and product lines.
LeafyWell produces a broad selection of Cannabidiol a containing products such as tinctures, oils, creams and lotions, and edible gummy candies and seeks to expand its product lines. The advisory board for PYTG now includes members of the medical community representing a variety of specialty medical fields such as family medicine, cardiovascular medicine, as well as a recent addition of a Fellow of the American College of Surgeons, just to name a few.
CEO of PYTG, Carlos Hurtado, states “We are excited to announce to the public today the official closing of the acquisition of NxGen Brands, LLC and especially the acquisition of LeafyWell along with the CBD containing product lines. We feel that we are right on schedule with the acquisition with our letter of intent filed earlier this summer and our acquisition closing now in October. Everything looks to be lining up exactly as we set out.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: October 29, 2018
Source: Cision